ABAndrew J. Boileau

Andrew J. Boileau

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Andrew J. Boileau has a total of 9 co-authors. Here are the top co-authors by number of shared publications:

  • Cynthia Czajkowski

    Department of Physiology, University of Wisconsin-Madison, Madison, Wisconsin 53711

    1 shared publication
  • Feyza Sancar

    Neuroscience Training Program, University of Wisconsin-Madison, Madison, USA

    1 shared publication
  • Jeremy D. Bushman

    Department of Physiology, University of Wisconsin-Madison, Madison, USA

    1 shared publication
  • José L. Mercado

    Neuroscience Training Program, University of Wisconsin-Madison, Madison, USA

    1 shared publication
  • Kelly R. Christopherson

    Molecular and Cellular Pharmacology Program, University of Wisconsin-Madison, Madison, USA

    1 shared publication
  • Robert A. Pearce

    Department of Anesthesiology, University of Wisconsin-Madison, Madison, WI, USA

    1 shared publication

Latest Publications

    • 1 February 2007
      • Vol. 35  (1) , 113-28

    Tandem couture: Cys-loop receptor concatamer insights and caveats.

    by Spencer S Ericksen, Andrew J Boileau

    Receptor subunits in the Cys-loop superfamily assemble to form channels as homopentamers or heteropentamers, expanding functional diversity through modularity. Expression of two or more compatible subunit types can lead to various receptor assemblies or subtypes. However, what may be good for diversity in vivo may be undesirable for the bench scientist, because we often wish to reduce our analyses to a single receptor subtype. By linking two or more subunits, creating tandems or concatamers, we can control stoichiometry and limit expression to exactly one receptor subtype. In this fashion, receptors with mixed subunit subtypes and heterozygous mutations can be separated from a mixture and can be described in detail. However, several recent studies have shown that this may be more easily conceived than accomplished, because several unforeseen problems have arisen. Concatamers can degrade, linkers can sometimes be clipped after or during translation, and one subunit may "loop out" or even become part of a second (now linked) pentamer with different characteristics. Some strategies have been developed to overcome these drawbacks, and the resultant new information that has begun to emerge has revitalized the study of these receptors in heterologous expression systems.


  • Tandem couture

    by Spencer S. Ericksen, Andrew J. Boileau


  • Optimized expression vector for ion channel studies in Xenopus oocytes and mammalian cells using alfalfa mosaic virus

    by Srinivasan P. Venkatachalan, Jeremy D. Bushman, José L. Mercado, Feyza Sancar, Kelly R. Christopherson, Andrew J. Boileau

    Plasmid vectors used for mammalian expression or for in vitro cRNA translation can differ substantially and are rarely cross-compatible. To make comparisons between mammalian and Xenopus oocyte expression systems, it would be advantageous to use a single vector without the need for shuttle vectors or subcloning. We have designed such a vector, designated pUNIV for universal, with elements that will allow for in vitro or ex vivo expression in multiple cell types. We tested the expression of pUNIV-based cDNA cassettes using enhanced green fluorescent protein and two forms of the type A γ-aminobutyric acid receptor (GABAAR) and compared pUNIV to vectors optimized for expression in either Xenopus oocytes or mammalian cells. In HEK293 cells, radioligand binding was robust, and patch clamp experiments showed that subtle macroscopic GABAAR kinetics were indistinguishable from our previous results. In Xenopus oocytes, agonist median effective concentration measurements matched previous work using a vector optimized for oocyte expression. Furthermore, we found that expression using pUNIV was significantly enhanced in oocytes and was remarkably long-lasting in both systems.


  • Open Access

    Tandem Subunits Effectively Constrain GABAAReceptor Stoichiometry and Recapitulate Receptor Kinetics But Are Insensitive to GABAAReceptor-Associated Protein

    by Andrew J. Boileau, Robert A. Pearce, Cynthia Czajkowski

    GABAergic synapses likely contain multiple GABAAreceptor subtypes, making postsynaptic currents difficult to dissect. However, even in heterologous expression systems, analysis of receptors composed of α, β, and γ subunits can be confounded by receptors expressed from α and β subunits alone. To produce recombinant GABAAreceptors containing fixed subunit stoichiometry, we coexpressed individual subunits with a “tandem” α1 subunit linked to a β2 subunit. Cotransfection of the γ2 subunit with αβ-tandem subunits in human embryonic kidney 293 cells produced currents that were similar in their macroscopic kinetics, single-channel amplitudes, and pharmacology to overexpression of the γ subunit with nonlinked α1 and β2 subunits. Similarly, expression of α subunits together with αβ-tandem subunits produced receptors having physiological and pharmacological characteristics that closely matched cotransfection of α with β subunits. In this first description of tandem GABAAsubunits measured with patch-clamp and rapid agonist application techniques, we conclude that incorporation of αβ-tandem subunits can be used to fix stoichiometry and to establish the intrinsic kinetic properties of α1β2 and α1β2γ2 receptors. We used this method to test whether the accessory protein GABAAreceptor-associated protein (GABARAP) alters GABAAreceptor properties directly or influences subunit composition. In recombinant receptors with fixed stoichiometry, coexpression of GABARAP-enhanced green fluorescent protein (EGFP) fusion protein had no effect on desensitization, deactivation, or diazepam potentiation of GABA-mediated currents. However, in α1β2γ2S transfections in which stoichiometry was not fixed, GABARAP-EGFP altered desensitization, deactivation, and diazepam potentiation of GABA-mediated currents. The data suggest that GABARAP does not alter receptor kinetics directly but by facilitating surface expression of αβγ receptors.